Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study
Diabetes & Metabolism Journal · 01.05.2025 · 49 (3) · 448-461
DOI: 10.4093/dmj.2024.0100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.05.2025. Verfasst von Honglin Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cystatin C, Creatinine, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Capital Medical University.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Normalized creatinine-to-cystatin C ratio (NCCR) was reported to approximate relative skeletal muscle mass and diabetes risk. However, the association between NCCR and cardiometabolic multimorbidity (CMM) remains elusive. This study aimed to explore their relationship in a large-scale prospective cohort.
Methods
This study included 5,849 middle-age and older participants from the China Health and Retirement Longitudinal Study (CHARLS) enrolled between 2011 and 2012. The baseline NCCR was determined as creatinine (mg/dL)/cystatin C (mg/L)×10/body mass (kg). CMM was defined as the simultaneous occurrence of two or more of the following conditions: heart disease, stroke, and type 2 diabetes mellitus. Logistic regression analysis and Cox regression analysis were employed to estimate the relationship between NCCR and CMM. The joint effect of body mass index and NCCR on the risk of CMM were further analyzed.
Results
During a median 4-year follow-up, 227 (3.9%) participants developed CMM. The risk of CMM was significantly decreased with per standard deviation increase of NCCR (odds ratio, 0.72; 95% confidence interval, 0.62 to 0.85) after adjustment for confounders (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Capital Medical University
- Beijing Natural Science Foundation
Zitieren
APA
Sun, H., Wu, Z., Wang, G., & Liu, J. (2025). Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study. Diabetes & Metabolism Journal, 49(3), 448-461. https://doi.org/10.4093/dmj.2024.0100
Vancouver
Sun H, Wu Z, Wang G, Liu J. Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study. Diabetes & Metabolism Journal. 2025;49(3):448-461. doi:10.4093/dmj.2024.0100
BibTeX
@article{Sun2025,
author = {Sun, Honglin and Wu, Zhenyu and Wang, Guang and Liu, Jia},
title = {Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study},
journal = {Diabetes & Metabolism Journal},
year = {2025},
volume = {49},
number = {3},
pages = {448--461},
doi = {10.4093/dmj.2024.0100}
}
EUVIMED